Our study points towards CAF-mediated mechanisms leading to reduced overall survival in breast and pancreatic cancer patients with low stromal FAK expression and highlight possible metabolic/signalling pathways that could be targeted in these patients. The gene discussed is PTK2; the disease is familial pancreatic carcinoma.